Argo will receive an upfront payment of $160 million, an option for Profit & Loss split across multiple geographies and potential near-term equity
New targeted therapy offers hope for patients with unresectable or metastatic NSCLC harboring HER2 tyrosine kinase domain activating mutations
The trial is the largest to date evaluating Leqvio and the first to focus on patient-centered outcomes
Replicate will receive research funding and could potentially receive up to approximately US$550 million
Triggering global regulatory submissions this year for the treatment of obesity
The complex four-hour surgery was performed by a multidisciplinary team of doctors
The $700 million project is part of Roche’s $50 billion investment in US manufacturing, infrastructure and R&D
The company is bringing precision therapies for gynaecological cancers
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
The patient had been battling DFSP for over eight years, enduring multiple recurrences despite three previous surgeries
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
